BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need. The Company's pipeline currently includes three product candidates for the treatment of cancer.
8-9 April, 2014, BIO ASIA International Conference, Tokyo, Japan
23-26 June, 2014, BIO International Convention, San Diego, USA
BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have three antibody therapeutics in development. Find out more »
Latest Share Price
BioInvent is currently running early-stage clinical trials with its products. Click here to find out more »